期刊： ORAL ONCOLOGY, 2022; 124 ()
Objective: To explore the effects of elective neck irradiation (ENI) in clinically node-negative (cN0) sinonasal adenoid cystic carcinoma (SNACC). Mat......
期刊： ORAL ONCOLOGY, 2022; 135 ()
Objectives: While a number of genetic and epigenetic events contributing to adult nasopharyngeal carcinomas (aNPC) development has been established, t......
期刊： ORAL ONCOLOGY, 2022; 135 ()
Objectives: Molecular targeted therapies against vascular endothelial growth factor (VEGF) receptor (VEGFR) have been explored in the treatment of rec......
期刊： ORAL ONCOLOGY, 2022; 134 ()
Objective: Patients with locoregionally advanced nasopharyngeal carcinoma (LANPC) were assigned to dose and volume de-escalated intensity-modulated ra......
期刊： ORAL ONCOLOGY, 2022; 124 ()
Medication related osteonecrosis of the jaw (MRONJ) is a commonly observed adverse reaction after taking antiresorption and anti-angiogenic drugs. As ......
期刊： ORAL ONCOLOGY, 2022; 126 ()
Objective: Immunotherapy directed at the tumor microenvironment is effective in the treatment of head and neck squamous cell carcinoma (HNSCC). In con......
期刊： ORAL ONCOLOGY, 2022; 125 ()
Objective: Induction chemotherapy followed by concurrent chemoradiotherapy is the standard of care for patients with locoregionally advanced nasophary......
期刊： ORAL ONCOLOGY, 2022; 127 ()
Objectives: We aim to investigate the prognostic value of potential prognostic m6A-related lncRNAs in oral squamous cell carcinoma (OSCC) samples and ......
